Preliminary Drug Trial Results Give Hope to Those with a Common Form of Muscular Dystrophy

An experimental drug designed to treat one of the most common forms of muscular dystrophy successfully reduced levels of a rogue protein that causes the disease, according to preliminary results of a multi-site clinical trial that includes the University of Kansas Medical Center.